Filing Flows › Zymeworks (ZYME) › Q1 2026
Zymeworks (ZYME) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Zymeworks (ZYME) reported revenue of $2.4M for the first quarter 2026 (Q1 2026), -91% from a year earlier and -4% from the quarter before.
Zymeworks, Q1 2026: revenue $2.4M (-91% year over year), net loss $44.2M, operating cash flow −$45.7M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | -4% | -91% |
| Operating profit | −$47.1M | — | — |
| Net earnings | −$44.2M | — | — |
| Operating cash flow | −$45.7M | — | — |
What changed
Revenue was $2.4M in Q1 2026, down 91% year over year and down 4% from the previous quarter.
Operating costs exceeded revenue by $47.1M, an operating margin of -1956.7%. Total costs fell 6% while revenue fell 91%. The quarter ended with a net loss of $44.2M, wider than the previous quarter's $41.2M loss.
Operating cash flow was −$45.7M. Non-cash charges added back $1.1M of depreciation and amortization and $6.9M of share-based compensation. Working capital and other items used $9.6M. Capital expenditures of $216K exceeded it, leaving free cash flow of −$45.9M.
Questions
What was Zymeworks' revenue in the first quarter 2026?
Zymeworks (ZYME) reported revenue of $2.4M for the first quarter 2026 (Q1 2026), -91% from a year earlier and -4% from the quarter before.
Source: Zymeworks 10-Q on SEC EDGAR.